While gastroesophageal tumours have a low prevalence of BRCA mutations, low ataxia telangectasia mutated (ATM) tumours, which also demonstrate increased sensitivity to olaparib [15], [16], represent 13–22 % of gastroesophageal cancers [17]. This evidence concerns the gene ATM and neoplasm.